Changeflow GovPing Pharma & Drug Safety Patent for micheliolide compositions to increas...
Routine Notice Added Final

Patent for micheliolide compositions to increase muscle mass

Favicon for changeflow.com ChangeBridge: Patent Apps - Therapeutics (A61P)
Published April 2nd, 2026
Detected April 2nd, 2026
Email

Summary

USPTO published patent application US20260091019A1 by Korea Institute of Science and Technology for a pharmaceutical composition containing micheliolide as an active ingredient for increasing muscle mass, improving muscle function, or preventing or treating muscular disease. The application (No. 19302634) was filed August 18, 2025 and published April 2, 2026, listing 12 inventors including Myungsuk Kim and Choong-Gu Lee.

What changed

The USPTO published patent application US20260091019A1 disclosing a composition comprising micheliolide or a pharmaceutically acceptable salt thereof for therapeutic use in increasing muscle mass, improving muscular functions, or preventing/treating muscular diseases. The claimed invention relates to methods of administration to individuals in need, with the micheliolide composition purportedly providing effects including increased muscle strength, increased muscle weight, and increased muscle fiber. The application is classified under CPC codes A61K 31/365, A61K 9/0056, and A61P 21/06.

This document is a patent application publication, which is informational in nature and does not create any compliance obligations or regulatory requirements. Entities reviewing this publication should note this represents a potential future patent blocking similar compositions or methods in the US market. Pharmaceutical companies developing muscle wasting or muscular disease treatments should consider potential freedom-to-operate issues. No action is required unless the entity is actively developing micheliolide-based therapeutics.

Source document (simplified)

← USPTO Patent Applications

COMPOSITION FOR ENHANCING INCREASING MUSCLE MASS, IMPROVING MUSCULAR FUNCTIONS, OR PREVENTING OR TREATING MUSCULAR DISEASE CONTAINING MICHELIOLIDE

Application US20260091019A1 Kind: A1 Apr 02, 2026

Assignee

KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY

Inventors

Myungsuk KIM, Choong-Gu LEE, Hye-Young YOUN, Sun hee PARK, Kwang-Hyun CHA, Dae-geun SONG, Young Tae PARK, Jiyeon SI, Song Yi KOO, Hee Ju LEE, Sang Hoon JUNG, Hyejin KO

Abstract

The present invention relates to a composition for increasing muscle mass, improving muscle function, or preventing or treating muscle disease, comprising micheliolide or a pharmaceutically acceptable salt thereof. In addition, the present invention relates to a method for increasing muscle mass, improving muscle function, or preventing or treating muscular disease, comprising administering or taking a composition comprising micheliolide or a pharmaceutically acceptable salt thereof as an active ingredient to an individual in need. The micheliolide of the present invention has the outstanding effect of increasing muscle strength, increasing muscle weight, and increasing muscle fiber.

CPC Classifications

A61K 31/365 A61K 9/0056 A61P 21/06

Filing Date

2025-08-18

Application No.

19302634

View original document →

Named provisions

Abstract Assignee Inventors CPC Classifications Filing Date Application No.

Classification

Agency
USPTO
Published
April 2nd, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US20260091019A1

Who this affects

Applies to
Pharmaceutical companies Healthcare providers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Patent Filing
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Intellectual Property
Topics
Pharmaceuticals Intellectual Property

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: Patent Apps - Therapeutics (A61P) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.